⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Zoetis Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Zoetis Inc.
↗Parsippany, New Jersey, USA
Zoetis is the world's leading animal health company, dedicated to supporting customers and their businesses in more than 100 countries. Building on more than 70 years of experience, Zoetis discovers, develops, manufactures, and commercializes medicines, vaccines, diagnostics, and technologies for companion animals and livestock.
Originally a subsidiary of Pfizer, Zoetis became an independent, publicly traded company in 2013. The company operates through an integrated approach, focusing on the 'Continuum of Care'—predicting, preventing, detecting, and treating disease—to improve the health and well-being of animals.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:$9.5B
Founded:2013
Ownership:public
Status:operating
STOCK
Exchange:NYSE
Ticker:ZTS
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Monoclonal antibodies (mAb), Vaccines, Diagnostics, Genetics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Basepaws
Key Partnerships:Various research collaborations with academic institutions and biotech firms to expand into complementary spaces.
COMPETITION
Position:Leader
Competitors:Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco, IDEXX Laboratories
LEADERSHIP
Key Executives:
Kristin Peck - CEO
LINKS
Website:zoetis.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Zoetis Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.